Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Buckley

Showing results (311-320 of 353) with videos related to

Pageof 36
Sort By:
Journal of Oncology|January 18, 2019
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast CancerMatthew P Humphries, Sean Hynes, Victoria Bingham, et al.
Translational Oncology|October 31, 2020
Radiation-induced Bystander Effect (RIBE) alters mitochondrial metabolism using a human rectal cancer ex vivo explant modelAisling B Heeran, Helen P Berrigan, Croí E Buckley, et al.
Translational Oncology|March 4, 2022
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumoursMaria Davern, Marie-Claire Fitzgerald, Croí E Buckley, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|July 29, 2020
The AO trauma CPP bone infection registry: Epidemiology and outcomes of Staphylococcus aureus bone infectionMario Morgenstern, Christoph Erichsen, Matthias Militz, et al.
Cancers|October 2, 2020
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate CancerCharles M Haughey, Debayan Mukherjee, Rebecca E Steele, et al.
Cell Communication and Signaling : CCS|September 26, 2024
A SRC-slug-TGFβ2 signaling axis drives poor outcomes in triple-negative breast cancersCharlotte Zoe Angel, Shannon Beattie, Ezanee Azlina Mohamad Hanif, et al.
Nature Medicine|April 3, 2007
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cellsKatarzyna Maresz, Gareth Pryce, Eugene D Ponomarev, et al.
Frontiers in Oncology|August 21, 2023
Metformin is a metabolic modulator and radiosensitiser in rectal cancerCroí E Buckley, Rebecca M O'Brien, Timothy S Nugent, et al.
Chemistry & Biology|April 24, 2012
Structure-based design of supercharged, highly thermoresistant antibodiesAleksandr E Miklos, Christien Kluwe, Bryan S Der, et al.
Neurosurgical Focus|December 16, 2006
Phase II study of carboplatin (CBDCA) in progressive low-grade gliomasA Moghrabi, H S Friedman, D M Ashley, et al.
Pageof 36

Showing results (311-320 of 353) with videos related to

Sort By:
Pageof 36
Journal of Oncology|January 18, 2019
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast CancerMatthew P Humphries, Sean Hynes, Victoria Bingham, et al.
Translational Oncology|October 31, 2020
Radiation-induced Bystander Effect (RIBE) alters mitochondrial metabolism using a human rectal cancer ex vivo explant modelAisling B Heeran, Helen P Berrigan, Croí E Buckley, et al.
Translational Oncology|March 4, 2022
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumoursMaria Davern, Marie-Claire Fitzgerald, Croí E Buckley, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|July 29, 2020
The AO trauma CPP bone infection registry: Epidemiology and outcomes of Staphylococcus aureus bone infectionMario Morgenstern, Christoph Erichsen, Matthias Militz, et al.
Cancers|October 2, 2020
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate CancerCharles M Haughey, Debayan Mukherjee, Rebecca E Steele, et al.
Cell Communication and Signaling : CCS|September 26, 2024
A SRC-slug-TGFβ2 signaling axis drives poor outcomes in triple-negative breast cancersCharlotte Zoe Angel, Shannon Beattie, Ezanee Azlina Mohamad Hanif, et al.
Nature Medicine|April 3, 2007
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cellsKatarzyna Maresz, Gareth Pryce, Eugene D Ponomarev, et al.
Frontiers in Oncology|August 21, 2023
Metformin is a metabolic modulator and radiosensitiser in rectal cancerCroí E Buckley, Rebecca M O'Brien, Timothy S Nugent, et al.
Chemistry & Biology|April 24, 2012
Structure-based design of supercharged, highly thermoresistant antibodiesAleksandr E Miklos, Christien Kluwe, Bryan S Der, et al.
Neurosurgical Focus|December 16, 2006
Phase II study of carboplatin (CBDCA) in progressive low-grade gliomasA Moghrabi, H S Friedman, D M Ashley, et al.
Pageof 36